Rituximab for the treatment of refractory anti-glomerular basement membrane disease

BACKGROUND: Anti-glomerular basement membrane (anti-GBM) disease is a rare but severe autoantibody-mediated immune disorder. The typical clinical presentation includes rapidly progressive glomerulonephritis and often concurrent pulmonary hemorrhage. The present study is aimed to investigate the ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xue-Fen, Jia, Xiao-Yu, Yu, Xiao-Juan, Cui, Zhao, Zhao, Ming-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Clinical Studies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291707/
https://www.ncbi.nlm.nih.gov/pubmed/35820833
http://dx.doi.org/10.1080/0886022X.2022.2097405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291707/
https://www.ncbi.nlm.nih.gov/pubmed/35820833
http://dx.doi.org/10.1080/0886022X.2022.2097405

Ejemplares similares